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S an, Smoking is a known aetiological nrsk factor for cervical cancer. Smoking-related DNA damage
(DNA adducts). in cervical epithelial cells. has recently been demonstrated to suggest a causal role in the
development of cervical cancer. Human papillomavirus 16 (HPV 16) is a known oncogenic virus and is also
implicated as a cause of cervical cancer. It has been suggested that both smoking and HPV may act
synergisticallv in the development of cervical cancer. We have investigated the cervical DNA adduct level and
the prevalence of HPV 16 (using polymerase chain reaction) in women who had normal cervical cytology.
Both the DNA adduct assay and the HPV assay were camred out on exfoliated cervical cells recovered from
cernical scrapes. In 87% of the cases there was enough DNA from the exfoliative cervical cells to analyse for
DNA adducts. Smokers had higher DNA adduct levels than non-smokers (P = 0.002). confinning the previous
data from cerVical biopsy samples. Forty-two per cent of the specimens were found to be HPV 16 positive.
There was no significant difference in smoking-related DNA damage (DNA adduct levels) between HPV-
positive and HPV-negative smokers. This suggests that smoking DNA damage does not augment HPV
infectivity. These results do not, therefore, support the molecular synergism theory.
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Numerous epidemiological studies have shown that smoking
is a risk factor for cervical cancer (Winkelstein, 1990).
Molecular research has recently demonstrated that the
presence of smoking-related DNA adducts (chemical car-
cinogens that exert their biological activity through covalent
modification of DNA) is significantly higher in the cervical
DNA of smokers than non-smokers (Simons et al.. 1993).
This suggests that smoking may play a causal role in the
development of cervical cancer.
Human papillomavirus 16 (HPV 16) is a known oncogenic
virus (Dyson et al.. 1989: Werness et al.. 1990) which is
present in the female genital tract. There is evidence that the
virus may contribute to the genesis of cervical cancer and
cervical intraepithelial neoplasia (Van Den Brule et al.. 1991;
Schiffman et al.. 1993). It has been suggested that HPV may
act synergistically with tobacco products (Zur Hausen, 1982)
or that tobacco products may allow penetrance of HPV by
causing local immunosuppression within the cervix (Barton et
al., 1988).
The Basque region of Spain is known to have a low
incidence of cervical cancer (Mugica van Herckenrode et al..
1992), whereas the prevalence of HPV (using slot-blot hy-
bridisation) in the cervices of these Spanish women has
previously been demonstrated to be similar to that found in
countries with a high incidence rate of cervical cancer
(Mugica van Herckenrode et al., 1992). This supports the
case for HPV 16 acting synergistically with some other agent.
We have investigated the prevalence of HPV 16. using
polymerase chain reaction (PCR). in Spanish women from
the Basque region who had normal cervical cytology. We
have correlated this with DNA adduct levels in the cervix.
Both the DNA adduct assay and the HPV assay were carried
out on exfoliated cervical cells recovered from cervical
scrapes. after the preparation of a routine Papanicolaou
smear.
Materials and methods
Subjects and samples
Thirty-eight Spanish women who live in the Basque region of
Spain were recruited into the study. All were undergoing a
routine cervical smear test at a gynaecology clinic.
The cervical scrape was taken by an experienced
gynaecologist using an Ayre spatula. The cells from the
spatula were spread on a slide, which was then fixed with
alcohol. The spatula was broken off into 10 ml of phosphate-
buffered saline and stored at - 20'C until DNA extraction.
All women answered a questionnaire on their smoking
habit. They were asked whether they had ever (currently or
previously) smoked. If they had, then the duration, number
of cigarettes smoked per day and last time they smoked were
recorded. Women who reported to have never smoked were
recorded as such.
Cv tologv
Cervical smears were stained by a modification of the
Papanicolaou (Coleman and Evans, 1988) method and the
slides analysed by an experienced cytologist (CMvH).
DNA extraction
DNA was isolated from the thawed spatula specimens essen-
tially as described previously (Phillips et al.. 1990).
One-quarter of the DNA yield was separated under sterile
conditions. This aliquot of the DNA was used exclusively for
HPV studies. The remaining DNA was used for 32P post-
labelling and its DNA yield was calculated spectrophoto-
metrically.
3'P post-labelling
Samples of 4;Lg of DNA were digested with micrococcal
nuclease and spleen phosphodiesterase then extracted with
butanol in an enhancement process as descnrbed previously
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1994(Gupta. 1985). Butanol phase residues were 3'P post-labelled
(Gupta et al.. 1982: Phillips et al.. 1988) by incubation with
[M-_3P]ATP (ICN Biochemicals. High Wycombe. Bucks. UK)
and T4 polynucleotide kinase. The reaction was stopped by
addition of apyrase. Resolution of 32P-labelled adducts was
carried out by multidirectional chromatography on poly-
ethyleneimine (PFI)-cellulose thin-layer chromatography
sheets using solvents and directions described previously
(Gupta et al., 1982): Dl. 1 M sodium phosphate, pH 6 (over-
night. onto a filter paper wick): D2. 3.5 M lithium for-
mate-8.5 M urea. pH 3.5 (opposite direction to Dl): D3.
0.8 M lithium chloride-0.5 M Tris-HCI-8.5 M urea, pH 8
(90 to D2): D4. 1.7 M sodium phosphate, pH 6 (onto filter
paper wick, same direction as D3). Detection of radioactive
material on the chromatograms (after removal of origin area)
was by autoradiography at - 75°C. The areas of the
chromatograms containing the radioactive material were
excised and assayed for radioactivity by Cerenkov counting,
while an area not containing significant radioactivity was also
excised and counted to provide a background level. The
extent of DNA modification was calculated from the levels of
radioactivity on the relevant areas of the chromatograms and
the specific activity of the [a-32P]ATP (Reddy and Randerath,
1986). The levels were expressed as total DNA adducts per
108 nucleotides.
HPV detection
HPV 16 detection was camred out using PCR with the primer
pair 9965 and 5163. which amplify a 35 bp fragment from
within the HPV 16 E6 open reading frame (ORF), as previ-
ously described (Jalal et al.. 1992). All experiments were
carried out in a dedicated sterile hood, using UV-irradiated
sterile PCR pipettes and tips. All solutions were treated to
prevent cross-contamination of samples, and PCR reaction
'master mixes' containing all components except cervical
DNA were prepared in a separate location, sealed with
Ampliwax (Perkin-Elmer) and analysed in duplicate in ran-
dom order. All duplicate samples gave identical results after
breaking the code.
PCR conditions were as follows: denaturation at 94°C for
4 min followed by 30 cycles of 94°C for 1 min. 50°C for
1 min. 72'C for 1 min then 72'C for 6 min. PCR products
were separated on an agarose gel and transferred onto
Hybond N+ membranes (Amersham). To intensify the signal.
duplicate filters were hybridised with both digoxigenin- and
32P-labelled PCR products from the E6 gene. Several faint
positives were confirmed (in duplicate) by this intensification.
Negative controls from known HPV 16-negative human pro-
state DNA and laboratory water were included at random in
the reaction series. All samples were negative even after the
intensification. whereas HPV 16-positive human tissues, from
cervical carcinoma tissue DNA. produced strong and repro-
ducible positive reactions.
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tent wvith HPV infection. None had evidence of cervical
intraepithelial neoplasia or invasive cervical cancer.
Twenty women reported that they were smokers (mean age
32 years; range 22-51). 18 reported being non-smokers
(mean age 35 years: range 18-57). There were no reported
ex-smokers. The DNA yield from each sample varied from
<4gg to 32pg. A minimum of 4fig of DNA is required for
analysis by 3P post-labelling. Five samples (13.2%). two
from smokers and three from non-smokers. contained
insufficient DNA to undergo 3-P post-labelling. The
chromatograms of the 33 adequate samples revealed a diag-
nonal zone of radioactivity (see Figure 1). This is indicative
of bulky aromatic DNA adducts and similar to that seen in
previous human cervical samples (Cuzick et al.. 1990: Phillips
et al.. 1990: Simons et al.. 1993). The range of adduct levels
was from 2.89 to 16.17 adducts 10' nucleotides (see Figure
2). The median DNA adduct level of the smokers was 8.55
adducts 10' nucleotides (95% CI 6.55-9.97) compared with
4.94 adducts 10' nucleotides (95% CI 4.18-5.88) of non-
smokers. Self-reported smokers had significantly higher DNA
adduct levels than non-smokers (P = 0.002) (see Figure 2).
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Method ofanalysis
Women were designated smokers or non-smokers on the
basis of self-reported smoking habit. The DNA adduct levels
of women who smoked were compared with the DNA adduct
levels of non-smokers. In addition to the DNA adducts, the
HPV status of each specimen was also compared between
smokers and non-smokers.
Statistical calculations
The non-parametric Mann-Whitney L-test was applied.
Results
All smears taken from the 38 women enrolled into the study
were suitable for cytological analysis. Thirty-three women
had normal cervical smears. Four had inflammatory atypia
and one had normal cytology associated with changes consis-
Figure 1 Autoradiographs of PEI-cellulose thin-layer
chromatographx maps of 3-P-labelled digests of DNA from
exfoliated human cervical cells. The origin is located in the
bottom left-hand corner of each chromatogram and has been
excised prior to autoradiographv for 2.5 davs at - 75'C. The
specific activity of the 3 P is the same in both. a. Cervical DNA
from a smoker (9.12 DNA adducts 10' nucleotides). b. Cervical
DNA from a non-smoker (4.55 DNA adducts 10' nucleotides).
Radioactive ink. *isible as small dots at the peripheries of the
radiographs. was used to align the autoradiographs with the
chromatograms for quantification of adducts.Smoldrq DNAdamap &W HWV inc ces
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Fgue 2 DNA adduct levels from exfoliated cervical cells of
Spanish women smokers and non-smokers.
DNA analysis of the samples for HPV 16 indicated the
presence of viral DNA in 16 (42%) cases. Twelve of the 20
smokers (60%) and four of the 18 (22%) non-smokers were
HPV 16 DNA positive. Complete data on DNA adduct
levels were available on only 10 of the 12 smokers. The
median DNA adduct level of HPV 16-positive smokers was
8.03 adducts 108 nucleotides compared with 4.99 adducts
lo0 nucleotides of HPV 16-positive non-smokers (P = 0.01).
However, no significant difference was demonstrated in DNA
adduct levels between HPV 16-positive smokers and HPV
16-negative smokers or beteween HPV 16-positive non-
smokers and HPV 16-negative non-smokers (see Table I).
Diauio
Covalent modification of DNA to form DNA adducts is a
critical early step in chemical carcinogenesis (Hoffman and
Hecht, 1990), and therefore detection of DNA adducts pro-
vides evidence of exposure of the cervix to carcinogens.
The demonstration in this study of significantly higher
DNA adduct levels in smokers as compared with non-
smokers is consistent with previous work on cervical tissue
(Simons et al., 1993). This provides further molecular
evidence of smoking-related carcinogenic agents affecting the
DNA of the cervical epithelium.
The chromatograms of the samples revealed a diagonal
zone of radioactivity which was similar to that observed in
previous studies (Cuzick et al., 1990; Simons et al., 1993)
using cervical biopsy material. This study is unique as we
have demonstrated DNA adducts using DNA extracted from
exfoliative cervical cells. This confirms the hypothesis of our
pilot study (Phillips et al., 1990).
The HPV 16-positive rate (using PCR) of 42% was very
similar to that found previously (Bloomfield, 1991). This rate.
among Spanish women from the Basque region, is higher
than previously reported (Mugica van Herckenrode et al..
1992). However, the earlier work had used a less sensitive
technique (slot-blot hybridisation) for HPV DNA detection
(Ward et al., 1990).
The ability of HPV to act as an oncogenic virus is undis-
puted (Schiffman et al., 1993). In 1982, Zur Hausen sug-
gested that HPV may act synergistically with some other
chemical compounds, including tobacco products. In 1988.
Barton et at. suggested that smoking causes a local immuno-
Table I The median number of DNA adducts per 108 nucleotides in
exfoliative cervical cells of HPV-positive and HPV-negative smokers
and non-smokers
HPV positive HPV negative
Smokers (n = 18) 8.03 7.44
Non-smokers (n = 15) 4.99 4.60
Smokers HPV(+) vs non-smokers HPV(+). P = 0.01; smokers
HPV(+) vs smokers HPV(-) P = 0.22; non-smokers HPV(+) vs
non-smokers HPV(-) P = 0.8.
suppression within the cervix as a result of a decrease in the
number of Langerhans cells. This local immunosuppression
would therefore allow penetrance of HPV. Although other
confounding factors such as lifestyle may be present. there
was a significant difference (P = 0.01) between the HPV
16-positive smokers (60%) and non-smokers (22%). This
theoretical synergism between smoking and HPV has been
demonstrated in a larger epidemiological study. Herrero et al.
(1989) showed that the relative risk of developing cervical
cancer was increased in those women who were found to be
HPV positive and smoked (< 10 cigarettes per day.
RR = 5.5; > 10 cigarettes day. RR = 8.4) as compared with
those that were HPV positive and non-smokers (RR = 5.0).
We have shown that there are no significant difference in
smoking-related DNA damage (DNA adduct levels) between
HPV-positive and HPV-negative smokers. This suggests that
smoking DNA damage does not augment HPV infectivity.
These results do not, therefore. support the molecular syner-
gism theory. Smoking must either act as a direct carcinogenic
agent alone, as suggested previously (Simons et al.. 1993) or
by causing local immunosuppression which would allow in-
creased penetrance of HPV.
In this study we have been able to establish the HPV status
and the quantitative smoking-related DNA damage (DNA
adducts) in the samples. This additional information was
gained using excess cellular material from the spatula that
would otherwise have been thrown away. Using PCR detec-
tion for HPV, only very small amounts of DNA are needed,
but the 32P post-labelling technique for measurement of
smoking-related DNA damage needs a minimum of 4 ltg of
DNA. Despite this, we were able to extract adequate
amounts of DNA from 87% of the spatulas. With evidence
that smoking and HPV increases the risk of development of
cervical cancer, this novel approach provides molecular in-
formation additional to cytological analysis. This approach
provides the clinician with enhanced information and would
aid in management protocols by identifying those at greater
risk of developing cervical cancer.
The Basque region of Spain was chosen because a large
proportion of the women in this region smoke and the
incidence of HPV infectivity has previously been shown to be
similar to other countries (Mugica van Herckenrode et al.,
1992). We intend to extend this pilot study and continue
long-term follow-up to see if these additional tests can assist
in predicting which women are at greater risk of eventually
developing cervical cancer.
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